In addition to development of our own ANDAs, HPI is actively pursuing the expansion of our product line through strategic alliances.
We are interested in the acquisition or in-licensing of products with dermatological indications.
Please contact Kerry Colman, Director of Business Development, to present opportunities or to learn more about working with HPI.
kcolman@harrispharmaceutical.com
